Arrow Research search

Author name cluster

Habib Ganjgahi

Possible papers associated with this exact author name in Arrow. This page groups case-insensitive exact name matches and is not a full identity disambiguation profile.

7 papers
1 author row

Possible papers

7

YNIMG Journal 2025 Journal Article

Odense-Oxford PET Image Analysis (OPETIA): An FSL-based toolbox for multimodal neuroimaging

  • Mohammadtaha Parsayan
  • Sasan Andalib
  • Thomas Lund Andersen
  • Habib Ganjgahi
  • Poul Flemming Høilund-Carlsen
  • Abass Alavi
  • Mojtaba Zarei

F-fluorodeoxyglucose (FDG) PET and MRIs of healthy subjects and patients with Alzheimer's disease (AD) from the Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset using OPETIA and compared the SUVR measurements with those obtained from Statistical Parametric Mapping, version 12 (SPM12). The result of this comparison showed a close association between OPETIA and SPM12 results (p-value 〈 0.01, r 〉 0.8). OPETIA measurements were significantly (p-value 0.9, indicating a high reproducibility. We compared the group difference (control vs Alzheimer's disease) obtained from each toolbox using two-sample t-test and found significantly (p-value < 0.01) larger Cohen's d values for SUVRs from OPETIA (d = 0.22) than SPM12 (d = 0.04). We suggest that OPETIA is a user-friendly and robust tool for quantitative analysis of multimodal neuroimaging such as cerebral PET and MR images.

YNIMG Journal 2021 Journal Article

Comparing empirical kinship derived heritability for imaging genetics traits in the UK biobank and human connectome project

  • Si Gao
  • Brian Donohue
  • Kathryn S. Hatch
  • Shuo Chen
  • Tianzhou Ma
  • Yizhou Ma
  • Mark D. Kvarta
  • Heather Bruce

Imaging genetics analyses use neuroimaging traits as intermediate phenotypes to infer the degree of genetic contribution to brain structure and function in health and/or illness. Coefficients of relatedness (CR) summarize the degree of genetic similarity among subjects and are used to estimate the heritability – the proportion of phenotypic variance explained by genetic factors. The CR can be inferred directly from genome-wide genotype data to explain the degree of shared variation in common genetic polymorphisms (SNP-heritability) among related or unrelated subjects. We developed a central processing and graphics processing unit (CPU and GPU) accelerated Fast and Powerful Heritability Inference (FPHI) approach that linearizes likelihood calculations to overcome the ∼N 2–3 computational effort dependency on sample size of classical likelihood approaches. We calculated for 60 regional and 1. 3 × 105 voxel-wise traits in N = 1, 206 twin and sibling participants from the Human Connectome Project (HCP) (550 M/656 F, age = 28. 8 ± 3. 7 years) and N = 37, 432 (17, 531 M/19, 901 F; age = 63. 7 ± 7. 5 years) participants from the UK Biobank (UKBB). The FPHI estimates were in excellent agreement with heritability values calculated using Genome-wide Complex Trait Analysis software (r = 0. 96 and 0. 98 in HCP and UKBB sample) while significantly reducing computational (102–4 times). The regional and voxel-wise traits heritability estimates for the HCP and UKBB were likewise in excellent agreement (r = 0. 63–0. 76, p < 10−1 0). In summary, the hardware-accelerated FPHI made it practical to calculate heritability values for voxel-wise neuroimaging traits, even in very large samples such as the UKBB. The patterns of additive genetic variance in neuroimaging traits measured in a large sample of related and unrelated individuals showed excellent agreement regardless of the estimation method. The code and instruction to execute these analyses are available at www. solar-eclipse-genetics. org.

YNICL Journal 2020 Journal Article

Investigating microstructure of white matter tracts as candidate endophenotypes of Social Anxiety Disorder – Findings from the Leiden Family Lab study on Social Anxiety Disorder (LFLSAD)

  • Eline F. Roelofs
  • Janna Marie Bas-Hoogendam
  • Hanneke van Ewijk
  • Habib Ganjgahi
  • Steven J.A. van der Werff
  • Marjolein E.A. Barendse
  • P. Michiel Westenberg
  • Robert R.J.M. Vermeiren

BACKGROUND: Social anxiety disorder (SAD) is a mental illness with a complex, partially genetic background. Differences in characteristics of white matter (WM) microstructure have been reported in patients with SAD compared to healthy controls. Also, WM characteristics are moderately to highly heritable. Endophenotypes are measurable characteristics on the road from genotype to phenotype, putatively reflective of genetically based disease mechanisms. In search of candidate endophenotypes of SAD we used a unique sample of SAD patients and their family members of two generations to explore microstructure of WM tracts as candidate endophenotypes. We focused on two endophenotype criteria: co-segregation with social anxiety within the families, and heritability. METHODS: Participants (n = 94 from 8 families genetically vulnerable for SAD) took part in the Leiden Family Lab Study on Social Anxiety Disorder (LFLSAD). We employed tract-based spatial statistics to examine structural WM characteristics, being fractional anisotropy (FA), axial diffusivity (AD), mean diffusivity (MD) and radial diffusivity (RD), in three a-priori defined tracts of interest: uncinate fasciculus (UF), superior longitudinal fasciculus (SLF) and inferior longitudinal fasciculus (ILF). Associations with social anxiety symptoms and heritability were estimated. RESULTS: Increased FA in the left and right SLF co-segregated with symptoms of social anxiety. These findings were coupled with decreased RD and MD. All characteristics of WM microstructure were estimated to be at least moderately heritable. CONCLUSION: These findings suggest that alterations in WM microstructure in the SLF could be candidate endophenotypes of SAD, as they co-segregated within families genetically vulnerable for SAD and are heritable. These findings further elucidate the genetic susceptibility to SAD and improve our understanding of the overall etiology.

YNIMG Journal 2017 Journal Article

ENIGMA and the individual: Predicting factors that affect the brain in 35 countries worldwide

  • Paul M. Thompson
  • Ole A. Andreassen
  • Alejandro Arias-Vasquez
  • Carrie E. Bearden
  • Premika S. Boedhoe
  • Rachel M. Brouwer
  • Randy L. Buckner
  • Jan K. Buitelaar

In this review, we discuss recent work by the ENIGMA Consortium (http: //enigma. ini. usc. edu) – a global alliance of over 500 scientists spread across 200 institutions in 35 countries collectively analyzing brain imaging, clinical, and genetic data. Initially formed to detect genetic influences on brain measures, ENIGMA has grown to over 30 working groups studying 12 major brain diseases by pooling and comparing brain data. In some of the largest neuroimaging studies to date – of schizophrenia and major depression – ENIGMA has found replicable disease effects on the brain that are consistent worldwide, as well as factors that modulate disease effects. In partnership with other consortia including ADNI, CHARGE, IMAGEN and others 1 1 Abbreviations: ADNI, Alzheimer's Disease Neuroimaging Initiative (http: //www. adni-info. org); CHARGE, the Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium (http: //www. chargeconsortium. com); IMAGEN, IMAging GENetics Consortium (http: //www. imagen-europe. com). , ENIGMA's genomic screens – now numbering over 30, 000 MRI scans – have revealed at least 8 genetic loci that affect brain volumes. Downstream of gene findings, ENIGMA has revealed how these individual variants – and genetic variants in general – may affect both the brain and risk for a range of diseases. The ENIGMA consortium is discovering factors that consistently affect brain structure and function that will serve as future predictors linking individual brain scans and genomic data. It is generating vast pools of normative data on brain measures – from tens of thousands of people – that may help detect deviations from normal development or aging in specific groups of subjects. We discuss challenges and opportunities in applying these predictors to individual subjects and new cohorts, as well as lessons we have learned in ENIGMA's efforts so far.

YNICL Journal 2015 Journal Article

Classification algorithms with multi-modal data fusion could accurately distinguish neuromyelitis optica from multiple sclerosis

  • Arman Eshaghi
  • Sadjad Riyahi-Alam
  • Roghayyeh Saeedi
  • Tina Roostaei
  • Arash Nazeri
  • Aida Aghsaei
  • Rozita Doosti
  • Habib Ganjgahi

Neuromyelitis optica (NMO) exhibits substantial similarities to multiple sclerosis (MS) in clinical manifestations and imaging results and has long been considered a variant of MS. With the advent of a specific biomarker in NMO, known as anti-aquaporin 4, this assumption has changed; however, the differential diagnosis remains challenging and it is still not clear whether a combination of neuroimaging and clinical data could be used to aid clinical decision-making. Computer-aided diagnosis is a rapidly evolving process that holds great promise to facilitate objective differential diagnoses of disorders that show similar presentations. In this study, we aimed to use a powerful method for multi-modal data fusion, known as a multi-kernel learning and performed automatic diagnosis of subjects. We included 30 patients with NMO, 25 patients with MS and 35 healthy volunteers and performed multi-modal imaging with T1-weighted high resolution scans, diffusion tensor imaging (DTI) and resting-state functional MRI (fMRI). In addition, subjects underwent clinical examinations and cognitive assessments. We included 18 a priori predictors from neuroimaging, clinical and cognitive measures in the initial model. We used 10-fold cross-validation to learn the importance of each modality, train and finally test the model performance. The mean accuracy in differentiating between MS and NMO was 88%, where visible white matter lesion load, normal appearing white matter (DTI) and functional connectivity had the most important contributions to the final classification. In a multi-class classification problem we distinguished between all of 3 groups (MS, NMO and healthy controls) with an average accuracy of 84%. In this classification, visible white matter lesion load, functional connectivity, and cognitive scores were the 3 most important modalities. Our work provides preliminary evidence that computational tools can be used to help make an objective differential diagnosis of NMO and MS.

YNIMG Journal 2015 Journal Article

Fast and powerful heritability inference for family-based neuroimaging studies

  • Habib Ganjgahi
  • Anderson M. Winkler
  • David C. Glahn
  • John Blangero
  • Peter Kochunov
  • Thomas E. Nichols

Heritability estimation has become an important tool for imaging genetics studies. The large number of voxel- and vertex-wise measurements in imaging genetics studies presents a challenge both in terms of computational intensity and the need to account for elevated false positive risk because of the multiple testing problem. There is a gap in existing tools, as standard neuroimaging software cannot estimate heritability, and yet standard quantitative genetics tools cannot provide essential neuroimaging inferences, like family-wise error corrected voxel-wise or cluster-wiseP-values. Moreover, available heritability tools rely on P-values that can be inaccurate with usual parametric inference methods. In this work we develop fast estimation and inference procedures for voxel-wise heritability, drawing on recent methodological results that simplify heritability likelihood computations (Blangero etal. , 2013). We review the family of score and Wald tests and propose novel inference methods based on explained sum of squares of an auxiliary linear model. To address problems with inaccuracies with the standard results used to find P-values, we propose four different permutation schemes to allow semi-parametric inference (parametric likelihood-based estimation, non-parametric sampling distribution). In total, we evaluate 5 different significance tests for heritability, with either asymptotic parametric or permutation-basedP-value computations. We identify a number of tests that are both computationally efficient and powerful, making them ideal candidates for heritability studies in the massive data setting. We illustrate our method on fractional anisotropy measures in 859 subjects from the Genetics of Brain Structure study.

YNIMG Journal 2014 Journal Article

Imaging proteomics for diagnosis, monitoring and prediction of Alzheimer's disease

  • Arash Nazeri
  • Habib Ganjgahi
  • Tina Roostaei
  • Thomas Nichols
  • Mojtaba Zarei

Proteomic and imaging markers have been widely studied as potential biomarkers for diagnosis, monitoring and prognosis of Alzheimer's disease. In this study, we used Alzheimer Disease Neuroimaging Initiative dataset and performed parallel independent component analysis on cross sectional and longitudinal proteomic and imaging data in order to identify the best proteomic model for diagnosis, monitoring and prediction of Alzheimer disease (AD). We used plasma proteins measurement and imaging data from AD and healthy controls (HC) at the baseline and 1year follow-up. Group comparisons at baseline and changes over 1year were calculated for proteomic and imaging data. The results were fed into parallel independent component analysis in order to identify proteins that were associated with structural brain changes cross sectionally and longitudinally. Regression model was used to find the best model that can discriminate AD from HC, monitor AD and to predict MCI converters from non-converters. We showed that five proteins are associated with structural brain changes in the brain. These proteins could discriminate AD from HC with 57% specificity and 89% sensitivity. Four proteins whose change over 1year were associated with brain structural changes could discriminate AD from HC with sensitivity of 93%, and specificity of 92%. This model predicted MCI conversion to AD in 2years with 94% accuracy. This model has the highest accuracy in prediction of MCI conversion to AD within the ADNI-1 dataset. This study shows that combination of selected plasma protein levels and MR imaging is a useful method in identifying potential biomarker.